March 23, 2018
Sandoz receives positive CHMP opinion for proposed biosimilar infliximab
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
March 22, 2018
First Japanese company joins CARB-X partnership in the fight against drug resistant bacteria
CARB-X is partnering with Shionogi of Osaka, Japan, to support the development of a novel β-lactam antibiotic with potent activity…
March 21, 2018
Sobi launches Ravicti in Europe and advances the care for patients with Urea Cycle Disorders
Swedish Orphan Biovitrum has gained reimbursement for Ravicti, a new therapy option for the treatment of patients with Urea Cycle…
March 20, 2018
Hikma launches Ritonavir Tablets USP
Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to…
March 2, 2018
BMS welcomes new Board member
Bristol-Myers Squibb’s Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga will…
February 28, 2018
EMA grants accelerated assessment for Shire’s Lanadelumab being evaluated for the prevention of attacks in Hereditary Angioedema patients aged 12 years and older
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted an accelerated assessment for…
February 28, 2018
Novo Nordisk files for regulatory approval in the US and the EU for treatment of haemophilia A
Novo Nordisk has submitted a Biologics License Applications (BLA) to the US Food and Drug Administration (FDA) and a Marketing…
February 28, 2018
FDA rejects Celgene’s NDA for multiple sclerosis treatment
Celgene Corporation (NASDAQ:CELG) has received a Refusal to File letter from the United States Food and Drug Administration (FDA) regarding its New Drug…
February 27, 2018
BASF reports 26% EBIT increase in chemical business
BASF has reported financial results for the year 2017. The company said that following a successful 2017 business year, BASF…
February 27, 2018
Lillys breast cancer drug gets additional FDA approval
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s (NYSE: LLY) Verzenio (abemaciclib) in combination with an aromatase…